MetaCap

Bioceres Crop Solutions Corp. (BIOX)

NASDAQ: BIOXIndustrialsAgricultural ChemicalsUSD

0.173-0.0099 (-5.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BIOX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$11.04M
EPS (TTM)
-$1.20
52-week range
0.1619 – 1.73
Day range
0.1619 – 0.18
Volume / Avg
130.22K / 304.62K
Beta
—

52-week range

$0.1619$1.73

BIOX stock today

Bioceres Crop Solutions (BIOX) closed at $0.173 on Nov 20, down 5.41% (-$0.0099), versus the S&P 500's 3.70% decline. Trading was light, with 130.22K shares changing hands, about 43% of the average daily volume. At this level, BIOX sits near the bottom of its 52-week range of $0.1619 to $1.73: 90.0% below the high, set on Nov 28, 2025 and 6.9% above the low.

BIOX is down 86.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 88.4%. Bioceres Crop Solutions has posted a net loss over the last twelve months (EPS of -$1.20), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Bioceres Crop Solutions

Company profile

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.

Industry
Agricultural Chemicals
CEO
Dr. Federico Trucco Ph.D.
Headquarters
Rosario

Financial highlights

Full financials

In fiscal 2025, Bioceres Crop Solutions generated $335.1 million in revenue, down 27.9% from fiscal 2024, the first decline in the 9 years shown. Bioceres Crop Solutions reported a net loss of $55.4 million, compared with net income of $4.3 million a year earlier. Gross margin was 39.3% (down from 40.1%) and operating margin -0.7%.

Bioceres Crop Solutions annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$335.11M$464.78M$420.06M$334.84M$209.53M
Growth-27.90%+10.65%+25.45%+59.81%+21.05%
Net income$-55.42M$4.28M$18.78M$-7.20M$-6.87M
EPS (diluted)$-0.8764$0.0673$0.2972$-0.1702$-0.1752

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$-0.12 vs —

BIOX news

All BIOX news

Bioceres Crop Solutions peers

Industrials sector
BIOX peer companies
CompanyPrice% ChgMarket capCompare
FRTTFort Technology Inc.0.47-9.79%$7.14Mvs BIOX
EVGNEvogene Ltd0.3162+1.02%$5.71Mvs BIOX
SNESSenesTech Inc.0.69+6.15%$4.71Mvs BIOX
AVDAmerican Vanguard Corporation0.68-1.48%$20.10Mvs BIOX
NXTSNexentis Technologies Inc.1.58-7.06%$1.05Mvs BIOX
ICLICL Group Ltd.4.08-1.45%—vs BIOX
UANCVR Partners LP95.09-0.88%—vs BIOX
CBUSCibus Inc. Class A1.21-1.63%$92.73Mvs BIOX

Indexes, lists and sector

Bioceres Crop Solutions stock FAQ

What is Bioceres Crop Solutions's stock price today?

BIOX last traded at $0.173 as of Nov 20, 4:00 PM EST, down 5.41% on the day. Prices are delayed at least 15 minutes.

Who is Bioceres Crop Solutions's CEO?

Dr. Federico Trucco Ph.D. is the chief executive officer of Bioceres Crop Solutions Corp..

What is the BIOX 52-week high?

The 52-week high for BIOX is $1.73 and the 52-week low is $0.1619. The stock is currently 90.0% below its high.

Compare BIOX